P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment

Indian Pacing and Electrophysiology Journal

Volumn 9, Issue 5, 2009, Pages 251-259

  Guntekin, Unal ^a   Gunes, Yilmaz ^a   Simsek, Hakki ^a   Tuncer, Mustafa ^a   Arslan, Sevket ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Hyperthyroidism; P wave dispersion; Propylthiouracil

Indexed keywords

LIOTHYRONINE; PROPYLTHIOURACIL; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DECELERATION; DIASTOLE; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; EUTHYROIDISM; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; P WAVE; RELAXATION TIME; RISK FACTOR; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 73249123910     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev 2005; 26: 704-28.
2. Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998; 27: 51-62.
3. Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a reversible cause of idiopathic atrial fibrillation. Am J Cardiol 1979; 44: 9-12.
4. Gilligan DM, Ellenbogen KA, Epstein AE. The management of atrial fi brillation. Am J Med 1996; 101: 413-21.
5. Sawin CT, Geller A, Wolf PA, at al. Low serum thyrotropin concentrations as a risk factor for atrial fi brillation in older persons. N Engl J Med 1994; 331: 1249-52.
6. Dilaveris PE, Gialafos EJ, Sideris SK, at al . Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733-8.
7. Aytemir K, Ozer N, Atalar E, at al. P-wave dispersion on 12-lead electrocardiogram in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 1109-12.
8. Steinberg JS, Zelenkofske S, Wong SC, at al. Value of P wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993; 88: 2618-22.
9. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, at al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 352-358.
10. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990; 88:631-7.
11. Forfar JC, Muir AL, Sawers SA, at al. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. N Engl J Med 1982; 307: 1165-70.
12. Polikar R, Burger AG, Scherrer U, at al. The thyroid and the heart. Circulation 1993; 87: 1435-41
13. Ching GW, Franklyn JA, Stallard TJ, at al. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 1996; 75: 363-8.
14. Fazio S, Palmieri EA, Lombardi G, at al. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31-50.
15. Biondi B, Palmieri EA, Lombardi G, at al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-14.
16. Biondi B, Palmieri EA, Lombardi G, at al. Subclinical hypothyroidism and cardiac function. Thyroid 2002; 12: 505-10.
17. Biondi B, Palmieri EA, Fazio S, at al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middleaged patients. J Clin Endocrinol Metab 2000; 85: 4701-05.
18. Lang RM, Bierig M, Devereux RB, at al; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiography 2005; 18: 1440-63.
19. Nagueh SF, Middleton KJ, Kopelen HA, at al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-33.
20. Buxton AE, Waxman HL, Marchlinski FE, at al. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol 1984; 54: 755-61.
21. Roithinger FX, Karch MR, Steiner PR. The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerability. J Interv Card Electrophysiol 1999; 3: 311-9.
22. Michelucci A, Bagliani G, Colella A, at al. P wave assessment: Statement of the art update. Card Electrophys Rev 2002; 6: 215-20.
23. Sun ZQ, Ojamaa K, Coetzee WA. Effects of thyroid hormone on action patetial and repolarizing currents in rat ventricular myocytes. Am J Physiol 2000; 278: 302-7.
24. Johnson PN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembran potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology 1973; 58: 273-89.
25. Han J, Leem C, So I, at al. Effects of thyroid hormone on the calcium current and isoparenaline-induced bacground current in rabbit ventricular myocytes. J Mol Cel Cardiol 1994; 26: 925-35.
26. Aras D, Maden O, Ozdemir O, at al. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol 2005; 99: 59-64.
27. Cacciatori V, Bellavere F, Pezzarossa A, at al. Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 1996; 81: 2828-35.
28. Tukek T, Akkaya V, Demirel S, at al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmalatrial fibrillation. Am J Cardiol 2000; 85: 896-9.
29. Katircibasi MT, Deniz F, Pamukcu B, at al. Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism. Exp Clin Endocrinol Diabetes. 2007; 115: 376-9.
30. Nakazawa HK, Sakurai K, Hamada N, at al. Management of atrial fi- brillation in the postthyrotoxic state. Am J Med 1982; 72: 903-6.
31. Gunduz H, Binak E, Arinc Hat al. The Relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J. 2005; 32: 163-7.
32. Smit JW, Eustatia-Rutten CF, Corssmit EP, at al . Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2005; 90: 6041-7.
33. Fazio S, Biondi B, Carella C, Sabatini at al. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of blockade. J Clin Endocrinol Metab 1995; 80: 2222-6.
34. Biondi B, Fazio S, Cuocolo A, at al. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1996; 81: 4224-8.
35. Mercuro G, Panzuto MG, Bina A, at al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 2000; 85: 159-64.
36. Dilaveris PE, Gialafos JE. P-wave duration and dispersion analysis: methodological considerations. Circulation 2001; 103: E111-1.